4576 JP - Announced Revisions to FY24/12 Earnings Forecasts
Net sales are expected to increase due to strong royalty income from ophthalmic surgical aid “DW-1002” in Europe, the United States, etc.
416 Views
D. Western Therapeutics Institute (DWTI) (4576 JP) - Q3 Follow-Up
For H-1337, DWTI completed dosing of subjects in the Phase IIb clinical trial in August, and top-line data was announced on November 18.
414 Views
D. Western Therapeutics Institute (4576 JP) - News Flash - November 19, 2024
DWTI announced topline results from its Phase 2B clinical trial of its H-1337 Ophthalmic Solution, for the treatment of elevated intraocular...
264 Views
D. Western Therapeutics Institute (4576 JP) - News Flash - Sep 5, 2024
DWTI announced that the first transplant was performed in a domestic Phase II clinical study of DWR-2206 (Indication: bullous keratopathy)
285 Views
D. Western Therapeutics Institute (DWTI) (4576 Jp) - 2Q Follow-Up
DWTI held a 1H results briefing via ZOOM webinar on Friday 8/23 at 13:30, hosted by President Hidaka. Several important points came up in his...
327 Views